THE CHILDREN'S MEDICAL CENTER CORP has a total of 30 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CANADIAN BLOOD SERVICES, UNIV GDAŃSKI and CHILDRENS MEDICAL CT CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Chemical engineering | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Diagnosis and surgery | |
#9 | Chemical or physical processes | |
#10 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Agarwal Suneet | 6 |
#2 | Kohane Daniel S | 4 |
#3 | Tahiliani Mamta | 4 |
#4 | Rao Anjana | 4 |
#5 | Koh Kian Peng | 4 |
#6 | Iyer Aravind | 4 |
#7 | Ozcan Umut | 3 |
#8 | Segal Matthew | 2 |
#9 | Boyraz Baris | 2 |
#10 | Moon Diane | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017223508A1 | Ventricular assist devices | |
WO2017210542A1 | Cross-genera target genome capture and analysis | |
WO2017192801A1 | Methods to purify avidin-like proteins and fusion proteins thereof | |
WO2017192708A1 | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells | |
WO2017070194A1 | Method to inhibit endothelial-to-mesenchymal transition | |
WO2017066796A2 | Modulators of telomere disease | |
WO2017066712A2 | Modulators of telomere disease | |
US2017368176A1 | Non-toxic topical anesthetic ophthalmic compositions | |
US2017333338A1 | Sustained and reversible oral drug delivery systems | |
US2017209408A1 | Hsp90 inhibitors for the treatment of obesity and methods of use thereof | |
US2014271843A1 | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |